RPL17P7: A Promising Drug Target / Biomarker (G100132742)

Target Name: RPL17P7

NCBI ID: G100132742

RPL17P7

Other Name(s): RPL17_3_82 | Ribosomal protein L17 pseudogene 7 | RPL17L | ribosomal protein L17 pseudogene 7

RPL17P7: A Promising Drug Target / Biomarker

The protein RPL17P7 is a key regulator of the poly(ADP-ribose) polymerase (PARP) complex, which is involved in the regulation of DNA repair and DNA replication. PARP is a transmembrane protein that consists of two subunits, Parp1 and Parp2, that are fused together in the N-terminus region. Parp1 is the catalytic subunit, while Parp2 is the structural subunit.

The RPL17P7 gene is located on chromosome 16 and encodes a protein with 1,742 amino acid residues. The protein has a unique structure that is composed of a long amino acid sequence, a short alpha-helices region, and a long beta-sheet region. The protein is expressed in most tissues of the body and is involved in various cellular processes, including DNA replication, repair, and cell growth.

The Role of RPL17P7 in DNA Replication

RPL17P7 is a key regulator of DNA replication, which is a critical process for the growth and development of most organisms. During DNA replication, RPL17P7 plays a critical role in the formation of the double helix.

The double helix is the structure that DNA replication uses to store the genetic information contained in the DNA molecule. During DNA replication, the two strands of the double helix are separated and then come together to form a double helix. RPL17P7 is involved in the formation of this double helix by playing a critical role in the regulation of the PARP complex.

The PARP complex is a protein that is involved in the regulation of DNA repair and replication. The PARP complex consists of the protein Parp1 and Parp2, which are fused together in the N-terminus region. Parp1 is the catalytic subunit, while Parp2 is the structural subunit.

During DNA replication, the PARP complex plays a critical role in the regulation of the double helix. The PARP complex uses a unique mechanism to ensure that the two strands of the double helix come together in the correct order. This mechanism involves the formation of a protein complex called DnaC, which consists of the protein Rec8 and the nucleotide DNA2.

The Rec8 protein is part of the RPL17P7 complex, which is responsible for the regulation of the PARP complex. Rec8 plays a critical role in the formation of the DnaC protein complex, which is required for the regulation of DNA replication.

The Role of RPL17P7 in DNA Repair

RPL17P7 is also involved in the regulation of DNA repair, which is an important process that helps to ensure the integrity of the genetic information contained in DNA. DNA repair is a critical process that helps to prevent genetic mutations, which can have harmful effects on the structure and function of the organism.

The PARP complex is involved in the regulation of DNA repair by using a unique mechanism to ensure that the damaged DNA is repaired in the correct order. This mechanism involves the formation of a protein complex called Rec9, which consists of the protein Rec8 and the nucleotide DNA1.

The Rec9 protein is part of the RPL17P7 complex, which is responsible for the regulation of the PARP complex. Rec9 plays a critical role in the formation of the Rec9 protein complex, which is required for the regulation of DNA repair.

The Role of RPL17P7 in Cell Growth

RPL17P7 is also involved in the regulation of cell growth, which is an important process that helps to ensure the survival and proliferation of cells. Cell growth is regulated by a variety of factors, including the availability of nutrients and oxygen, as well as the levels of various signaling molecules that are involved in cell growth

Protein Name: Ribosomal Protein L17 Pseudogene 7

The "RPL17P7 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RPL17P7 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets